Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 13, 2026, 1:15 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 313–336 of 399 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Testosterone Clear all

Conditions: Hypogonadism
Interventions: Testosterone; Drug
Lead sponsor: North Florida Foundation for Research and Education; Other
Eligibility: 60 Years to 80 Years · Male only
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Gender, Contraception
Interventions: Bleeding data; Behavioral
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years to 50 Years
Enrollment: 160 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: San Diego, California

Conditions: Type 2 Diabetes Mellitus, Hypogonadism
Interventions: Testosterone gel 1.62%, Placebo; Drug
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 35 Years to 70 Years · Male only
Enrollment: 92 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Male Hypogonadism
Interventions: testosterone gel 2%; Drug
Lead sponsor: Endo USA Inc., a Keenova Therapeutics Company; Industry
Eligibility: 18 Years to 65 Years · Male only
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 8
States / cities: Tucson, Arizona • Middlebury, Connecticut • Oviedo, Florida + 5 more

Conditions: Caloric Restriction, Exercise
Interventions: Sesame Oil, testosterone enanthate; Drug
Lead sponsor: Pennington Biomedical Research Center; Other
Eligibility: 18 Years to 39 Years · Male only
Enrollment: 53 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Obesity
Interventions: Leuprolide, Testosterone; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 50 Years · Male only
Enrollment: 39 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Sleep Restriction
Interventions: Ketoconazole Pill, Ganirelix, Dexamethasone, Dexamethasone Injection, Cosyntropin Injectable Product, Recombinant Human Luteinizing Hormone, Hydrocortisone Injection, Gonadorelin, Corticorelin, Placebo oral capsule, Saline Solution, Saline Solution for Injection; Drug
Lead sponsor: Peter y. Liu; Other
Eligibility: 22 Years to 45 Years · Male only
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2026
U.S. locations: 1
States / cities: Torrance, California

Conditions: Hypogonadism, Male, Fatigue Syndrome, Chronic
Interventions: Testosterone Undecanoate 750 MG/3 ML Intramuscular Solution [AVEED], placebo; Drug · Other
Lead sponsor: Seattle Institute for Biomedical and Clinical Research; Other
Eligibility: 18 Years to 54 Years · Male only
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 2
States / cities: Boston, Massachusetts • Seattle, Washington

Conditions: Healthy
Interventions: testosterone; Drug
Lead sponsor: Warner Chilcott; Industry
Eligibility: 20 Years to 70 Years · Female only
Enrollment: 110 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2008
U.S. locations: 4
States / cities: Fort Myers, Florida • Miramar, Florida • Overland Park, Kansas + 1 more

Conditions: Physical Frailty, Hip Fracture, Elective Hip Replacement, Hypogonadism
Interventions: Transdermal Testosterone gel (1%), Supervised exercise training; Drug · Behavioral
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 65 Years and older · Male only
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2009
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Hypogonadism, Male
Interventions: Testosterone Cypionate 200 Mg/ML, Intranasal Testosterone; Drug
Lead sponsor: University of Miami; Other
Eligibility: 18 Years to 75 Years · Male only
Enrollment: 81 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Healthy
Interventions: Testosterone injection, Testosterone gel, Testosterone Oral; Drug
Lead sponsor: Sports Medicine Research and Testing Laboratory; Industry
Eligibility: 18 Years to 60 Years · Male only
Enrollment: 14 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: South Jordan, Utah

Conditions: Testicular Hypogonadism
Interventions: Testosterone gel (FE 99903); Drug
Lead sponsor: Ferring Pharmaceuticals; Industry
Eligibility: 18 Years to 65 Years · Male only
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011
U.S. locations: 1
States / cities: Garden City, New York

Conditions: Hypogonadism
Interventions: dutasteride, placebo; Drug
Lead sponsor: The Miriam Hospital; Other
Eligibility: 40 Years to 85 Years · Male only
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 2
States / cities: Boston, Massachusetts • Providence, Rhode Island

Conditions: Primary or Secondary Hypogonadism, Constitutional Delay in Growth and Puberty (CDGP)
Interventions: Testosterone Gel (1%); Drug
Lead sponsor: Solvay Pharmaceuticals; Industry
Eligibility: 13 Years to 17 Years · Male only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2007
U.S. locations: 19
States / cities: Birmingham, Alabama • Los Angeles, California • Sacramento, California + 14 more

Conditions: Testosterone Deficiency, Estrogen Deficiency
Interventions: Joovv Infrared Light Device; Device
Lead sponsor: ProofPilot; Industry
Eligibility: 18 Years to 65 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020
U.S. locations: 1
States / cities: New York, New York

Conditions: Prostate Cancer, Prostatic Neoplasms
Interventions: Relugolix, Leuprolide; Drug
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 18 Years and older · Male only
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 3
States / cities: Boston, Massachusetts • Foxborough, Massachusetts

Conditions: Prostate Cancer
Interventions: Androderm® 2.5mg, Androderm® 5.0mg, Androderm® 7.5mg; Drug
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years and older · Male only
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2009
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Hypogonadism
Interventions: Not listed
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: Male only
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1993 – 2001
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Prostate Cancer, Metastatic Castration Resistant Prostate Cancer, Metastatic Castration-sensitive Prostate Cancer
Interventions: PRL-02 injection, prednisone, dexamethasone, enzalutamide; Drug
Lead sponsor: Astellas Pharma Global Development, Inc.; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 174 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2029
U.S. locations: 24
States / cities: Tucson, Arizona • Anaheim, California • Santa Rosa, California + 20 more

Conditions: Hypogonadism, Male
Interventions: SOV2012-F1, AndroGel; Drug
Lead sponsor: Marius Pharmaceuticals; Industry
Eligibility: 18 Years to 65 Years · Male only
Enrollment: 314 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 36
States / cities: Birmingham, Alabama • Mobile, Alabama • Tucson, Arizona + 31 more

Conditions: Polycystic Ovary Syndrome
Interventions: Metformin, Placebo, Lifestyle Intervention; Drug · Behavioral
Lead sponsor: Milton S. Hershey Medical Center; Other
Eligibility: 12 Years to 39 Years · Female only
Enrollment: 114 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2008
U.S. locations: 1
States / cities: Hershey, Pennsylvania

Conditions: Postoperative Nausea and Vomiting, Sex Hormone, Transgender
Interventions: Orchiectomy, Hysterectomy, Augmentation mammoplasty; Procedure
Lead sponsor: Riverside University Health System Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 7,348 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: Moreno Valley, California

Conditions: Prostate Adenocarcinoma
Interventions: Osanetant; Drug
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 18 Years and older · Male only
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 1
States / cities: Kansas City, Kansas

Search by objective public record fields.

Does Testosterone Improve Function in Hypogonadal Older Men

Impact of Progestin-only Contraception on Bleeding Patterns in Individuals Initiating GATT

Testosterone Therapy and Bone Quality in Men With Diabetes and Hypogonadism

Time to Eugonadal Range, Time to Steady State and Drying Time

Physiological and Psychological Effects of Testosterone During Severe Energy Deficit and Recovery

Influence of Male Hormones on Regional Fat Metabolism

Hormonal Mechanisms of Sleep Restriction - Axis Study

Testosterone Replacement in Male Cancer Survivors With Fatigue and Low Testosterone

Bioequivalence of Testosterone Reduced-size Patch Relative to the Testosterone Reference Patch

Exercise and Testosterone Therapy in Elderly Men With Physical Frailty

A Comparison of Side Effects in Hypogonadal Men Treated With Natesto Versus Testosterone Injections

Comparing Direct and Indirect Detection Methods of Multiple Routes of Testosterone Administration

Efficacy, Pharmacokinetics and Safety of Testosterone

Efficacy Study for Use of Dutasteride (Avodart) With Testosterone Replacement

Observation Study of T-Gel (1%) in Treatment of Adolescent Boys With Hypogonadism

Use of Infrared Photomodulation for Hormonal Balance (Joovvin' for Hormonal Health)

RecoverPC: Relugolix vs GnRH Agonist in Quality of Life

A Randomized Study of Testosterone Replacement in Patients With Low Risk Hormone Refractory Prostate Cancer

Effects on the Brain of Lupron Induced Hypogonadotropic Hypogonadism With and Without Testosterone Replacement

A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer

Efficacy and Safety of Oral Testosterone Undecanoate in Hypogonadal Men

Lifestyle Intervention and Metformin for Women With Polycystic Ovary Syndrome (PCOS)

Exogenous Sex Hormones and PONV

Pilot of Osanetant to Reduce Testosterone in Men With Adenocarcinoma of the Prostate